Recent studies showed that CX4945 induced down-regulation of the autophagosome-mediated EGFR in lung cancer [32], while EGFR inhibitors induced, in lung adenocarcinoma, activation of the HGF/Met pathway as a mechanism of drug resistance [33]. This evidence concerns the gene MET and lung carcinoma.